Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02542657
Recruitment Status : Recruiting
First Posted : September 7, 2015
Last Update Posted : March 2, 2018
Sponsor:
Collaborators:
Takeda
Celgene
Information provided by (Responsible Party):
University of California, Davis

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : July 2020